Debt-to-equity of American Oncology Network, Inc. from 30 Sep 2021 to 31 Dec 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: American Oncology Network, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 31 Dec 2024.
American Oncology Network, Inc. Debt-to-equity for the quarter ending 31 Dec 2024 was -404%, a 239% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

American Oncology Network, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q4 2024	-404%	-285%	-239%	31 Dec 2024
Q3 2024	-293%	-139%	-90%	30 Sep 2024
Q2 2024	-190%	+349%	+65%	30 Jun 2024
Q1 2024	-144%	+357%	+71%	31 Mar 2024
Q4 2023	-119%	+398%	+77%	31 Dec 2023
Q3 2023	-155%	+199%	+56%	30 Sep 2023
Q2 2023	-539%	-207%	-62%	30 Jun 2023
Q1 2023	-501%	-191%	-62%	31 Mar 2023
Q4 2022	-517%	-234%	-82%	31 Dec 2022
Q3 2022	-354%	-246%	-229%	30 Sep 2022
Q2 2022	-331%			30 Jun 2022
Q1 2022	-310%			31 Mar 2022
Q4 2021	-284%			31 Dec 2021
Q3 2021	-108%			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.